University of Toronto 160 College Street
Join Todd McDevitt Research Talk in the CCBR Red Room next Wed August 28th from 4-5pm.
Topic: Engineering the Morphogenesis of Pluripotent Stem Cells to Direct Organoid Formation.
Todd McDevitt, Ph.D. is a Senior Investigator at the Gladstone Institutes, a Professor in the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco, and Program Director for the UCSF/UC Berkeley Bioengineering Graduate Program. Before moving to the Gladstone Institutes in 2015, Dr. McDevitt was the Carol Ann and David D. Flanagan Professor in the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University, founding Director of the Stem Cell Engineering Center at Georgia Tech, and a Faculty Member and former Petit Faculty Fellow in the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech. Dr. McDevitt has 20 years of experience in biomaterials and tissue engineering research and for the past 15 years has focused on stem cell tissue engineering and regenerative medicine technologies. The primary objective of Dr. McDevitt’s research is to engineer technologies capable of directing differentiation and morphogenesis of stem cells more effectively in order to create new tissue models of development and disease, novel drug screening platforms, and regenerative medicine therapies. The McDevitt laboratory has been a leader in the development of novel 3D suspension culture platforms for stem cell morphogenesis and scalable biomanufacturing of stem cell-derived cell types. In addition to stem cell tissue engineering efforts, the McDevitt laboratory has also innovated several parallel approaches to develop stem cell-derived molecular therapies for immunomodulation, tissue repair and regeneration, and anti-aging applications.